IL6R and rheumatoid arthritis: Wang et al. [118] demonstrated that IL-6R antagonists reduced Th17 cell production mediated by IL-34-stimulated SFs in RA patients, thereby suppressing RA, indirectly suggesting high IL-6R expression in SFs correlates with disease activity.